Sheahan BJ - Search Results

1

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.

Morris-Downes MM, Sheahan BJ, Fleeton MN, Liljeström P, Reid HW, Atkins GJ. Morris-Downes MM, et al. Among authors: sheahan bj. Vaccine. 2001 Jul 16;19(28-29):3877-84. doi: 10.1016/s0264-410x(01)00126-8. Vaccine. 2001. PMID: 11427261

2

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

Atkins GJ, Sheahan BJ, Liljeström P. Atkins GJ, et al. Among authors: sheahan bj. J Gen Virol. 1999 Sep;80 ( Pt 9):2287-2297. doi: 10.1099/0022-1317-80-9-2287. J Gen Virol. 1999. PMID: 10501479 Review. No abstract available.

3

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

Jerusalmi A, Morris-Downes MM, Sheahan BJ, Atkins GJ. Jerusalmi A, et al. Among authors: sheahan bj. Mol Ther. 2003 Dec;8(6):886-94. doi: 10.1016/j.ymthe.2003.09.010. Mol Ther. 2003. PMID: 14664790 Free article.

4

Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.

Galbraith SE, Sheahan BJ, Atkins GJ. Galbraith SE, et al. Among authors: sheahan bj. J Gen Virol. 2006 Apr;87(Pt 4):937-947. doi: 10.1099/vir.0.81406-0. J Gen Virol. 2006. PMID: 16528043

5

Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.

Callagy SJ, Kelly BJ, Fleeton MN, Sheahan BJ, Galbraith SE, Atkins GJ. Callagy SJ, et al. Among authors: sheahan bj. Vaccine. 2007 Oct 23;25(43):7481-90. doi: 10.1016/j.vaccine.2007.08.049. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17905485

6

Therapeutic and prophylactic applications of alphavirus vectors.

Atkins GJ, Fleeton MN, Sheahan BJ. Atkins GJ, et al. Among authors: sheahan bj. Expert Rev Mol Med. 2008 Nov 11;10:e33. doi: 10.1017/S1462399408000859. Expert Rev Mol Med. 2008. PMID: 19000329 Review.

7

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

Fleeton MN, Sheahan BJ, Gould EA, Atkins GJ, Liljestr M P. Fleeton MN, et al. Among authors: sheahan bj. J Gen Virol. 1999 May;80 ( Pt 5):1189-1198. doi: 10.1099/0022-1317-80-5-1189. J Gen Virol. 1999. PMID: 10355766

8

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.

Fleeton MN, Liljeström P, Sheahan BJ, Atkins GJ. Fleeton MN, et al. Among authors: sheahan bj. J Gen Virol. 2000 Mar;81(Pt 3):749-58. doi: 10.1099/0022-1317-81-3-749. J Gen Virol. 2000. PMID: 10675413

9

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles.

Murphy AM, Morris-Downes MM, Sheahan BJ, Atkins GJ. Murphy AM, et al. Among authors: sheahan bj. Gene Ther. 2000 Sep;7(17):1477-82. doi: 10.1038/sj.gt.3301263. Gene Ther. 2000. PMID: 11001367

10

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

Morris-Downes MM, Phenix KV, Smyth J, Sheahan BJ, Lileqvist S, Mooney DA, Liljeström P, Todd D, Atkins GJ. Morris-Downes MM, et al. Among authors: sheahan bj. Vaccine. 2001 Feb 28;19(15-16):1978-88. doi: 10.1016/s0264-410x(00)00428-x. Vaccine. 2001. PMID: 11228368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters